ESR1 Control Kit (4 Vials + wt control)

A comprehensive cfDNA control kit featuring 16 unique ESR1 gene mutations distributed across four separate vials, plus a wild-type control vial. This multi-target kit provides a wide range of clinically relevant variants for oncology testing.

Designed for the validation and routine monitoring of liquid biopsy assays targeting ESR1 mutations, which are key biomarkers in breast cancer. It enables laboratories to verify the detection of multiple mutations, assess the limit of detection (LOD), and ensure the accuracy of NGS panels.

Lead time for this kit is 2-3 weeks. Each of the four mutation vials contains a distinct pool of four ESR1 variants, providing an efficient tool for comprehensive panel validation.